As of 2024-12-12, the EV/EBITDA ratio of Tandem Diabetes Care Inc (TNDM) is -21.89. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TNDM's latest enterprise value is 2,566.67 mil USD. TNDM's TTM EBITDA according to its financial statements is -117.23 mil USD. Dividing these 2 quantities gives us the above TNDM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 13.6x | 11.9x |
| Forward P/E multiples | 14.4x - 17.9x | 15.4x |
| Fair Price | (30.26) - (28.87) | (28.92) |
| Upside | -187.7% - -183.6% | -183.8% |
| Date | EV/EBITDA |
| 2024-12-11 | -21.89 |
| 2024-12-10 | -21.50 |
| 2024-12-09 | -20.54 |
| 2024-12-06 | -19.42 |
| 2024-12-05 | -19.51 |
| 2024-12-04 | -20.64 |
| 2024-12-03 | -21.25 |
| 2024-12-02 | -20.77 |
| 2024-11-29 | -19.72 |
| 2024-11-27 | -20.05 |
| 2024-11-26 | -19.38 |
| 2024-11-25 | -19.60 |
| 2024-11-22 | -19.82 |
| 2024-11-21 | -19.78 |
| 2024-11-20 | -19.45 |
| 2024-11-19 | -18.17 |
| 2024-11-18 | -18.67 |
| 2024-11-15 | -17.87 |
| 2024-11-14 | -18.57 |
| 2024-11-13 | -19.18 |
| 2024-11-12 | -19.98 |
| 2024-11-11 | -20.13 |
| 2024-11-08 | -19.70 |
| 2024-11-07 | -21.22 |
| 2024-11-06 | -21.74 |
| 2024-11-05 | -21.10 |
| 2024-11-04 | -20.96 |
| 2024-11-01 | -20.43 |
| 2024-10-31 | -20.13 |
| 2024-10-30 | -20.68 |
| 2024-10-29 | -21.00 |
| 2024-10-28 | -20.90 |
| 2024-10-25 | -20.12 |
| 2024-10-24 | -20.35 |
| 2024-10-23 | -20.57 |
| 2024-10-22 | -21.35 |
| 2024-10-21 | -21.66 |
| 2024-10-18 | -22.35 |
| 2024-10-17 | -22.06 |
| 2024-10-16 | -23.56 |
| 2024-10-15 | -23.63 |
| 2024-10-14 | -23.49 |
| 2024-10-11 | -23.32 |
| 2024-10-10 | -22.80 |
| 2024-10-09 | -24.47 |
| 2024-10-08 | -24.89 |
| 2024-10-07 | -25.96 |
| 2024-10-04 | -25.96 |
| 2024-10-03 | -25.22 |
| 2024-10-02 | -25.62 |